Abstract:OBJECTIVE:To search the role of Helicobacter pylori (H. pylori) in the progression of gastric carcinogenesis.METHODS:A cohort study was conducted by cluster randomized sampling in Linqu County, a rural area in Shandong Province in northeast China, where the mortality of gastric cancer (GC) is among the highest in the world. In 1989-1990, a gastroscopic examination and serum test was launched among subjects aged 35-64 from 14 randomized villages. Histological diagnosis of gastric mucosa and enzyme-linked immunosorbent assay was used to detect gastric lesions and anti-H. pylori of all participants. A repeated gastroscopic screening was offered to all cohort members in 1994 and 1999 respectively, and all the GC cases, regardless of natural ones or ones by gastroscopy, were registered in the follow-up periods.RESULTS:Fifty-eight cases of GC were identified in 2469 subjects during the 10-year follow-up, 44 were observed in 1603 H. pylori-positive persons (2.74%) and 14 in 866 H. pylori-negative persons (1.62%). The incidence rate of GC in H. pylori-positive is significantly higher than in H. pylori-negative (OR = 1.871, 95% CI: 1.012 - 3.459). There was no significant difference in the progression of gastric carcinogenesis between H. pylori-positive and H. pylori-negative (P > 0.05) among subjects with normal or superficial gastritis (SG) at baseline. In contrast, the significant difference was found in baseline chronic gastritis (CAG) group (P < 0.01), and the GC incidence rate in H. pylori-positive (7/615) is higher than in H. pylori-negative (0/470, P = 0.019). The difference of gastric lesions between H. pylori-positive and H. pylori-negative in subjects with intestinal metaplasia (IM) and dysplasia (DYS) at baseline was statistically significant after a 10-year follow-up (P < 0.05, P < 0.01, respectively), but the GC incidence rate in H. pylori-positive is similar to the rate in H. pylori-negative at the two groups (17/573 and 7/224 in IM group, P = 0.907; 19/368 and 7/122 in DYS group, P = 0.806).CONCLUSIONS:H. pylori is a key risk factor that prompts the transition from chronic atrophic gastritis to advanced precancerous lesions and influences the whole progression of precancerous gastric lesions. H. pylori, perhaps can not cause GC directly, increases the risk of GC in company with other carcinogens. H. pylori seemingly has no important effect on the development of GC when gastric mucosa is normal or superficial gastritis, but this conclusion is required to be further confirmed.

Helicobacter Pylori Antibody Responses and Evolution of Precancerous Gastric Lesions in a Chinese Population

[Serological Assessment of Helicobacter Pylori-Specific Antibodies and Their Association with Gastric Lesions in a High-Risk Population].

Helicobacter Pylori Antibodies in Relation to Precancerous Gastric Lesions in a High-Risk Chinese Population.

Distribution of H.pylori Antigens in Gastric Mucosa and Its Significance.

Helicobacter pylori antibodies in relation to precancerous gastric lesions in the high-risk Chinese population

Serum Antibodies to Helicobacter Pylori and the Caga Antigen Do Not Explain Differences in the Prevalence of Precancerous Gastric Lesions in Two Chinese Populations with Contrasting Gastric Cancer Rates

[Helicobacter Pylori and the Progression of Gastric Cancer: a 10-Year Cohort Study].

H. pylori Infection and the Anatomic Distribution of Chronic Atrophic Gastritis in a Population at High Risk of Gastric Cancer

Helicobacter Pylori Seropositivities and Risk of Pancreatic Carcinoma.

Association of Helicobacter pylori CagA seropositivity with gastric precancerous lesions: a systematic review and meta-analysis

Helicobacter pylori infection, H19 and LINC00152 expression in serum and risk of gastric cancer in a Chinese population

Abstract 1027: Helicobacter pylori blood biomarkers for gastric cancer risk in the Shanghai Men's Health Study

Helicobacter pylori Immunoproteomic Profiles in Gastric Cancer

Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis

Lessons learned from upper gastrointestinal endoscopy in asymptomatic Chinese

Helicobacter Pylori Prevalence and CagA Status among Children in Two Counties of China with High and Low Risks of Gastric Cancer.

Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions.

Evolution of Precancerous Lesions in a Rural Chinese Population at High Risk of Gastric Cancer

Validation of a blood biomarker for identification of individuals at high risk for gastric cancer.

Helicobacter Pylori Blood Biomarkers and Gastric Cancer Survival in China

Helicobacter Pylori Infection, Garlic Intake And Precancerous Lesions In A Chinese Population At Low Risk Of Gastric Cancer